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cartilage extracts. The dog ACLT model of acute injury showed
higher levels of TN-C in surgery knees at 1-month post surgery
(73-fold) and 3-months post surgery (48-fold) as compared to
control knees. Higher levels of TN-C were maintained in surgery
knees 6-months post surgery in this dog model. In the rat meniscal
tear model, there was a signiﬁcant increase (40-fold) in TN-C in
surgery knees at 1wk as compared to no surgery contralateral
controls, and this increase was maintained at 4 and 8 wks, albeit
with a smaller absolute difference from control.
Conclusions: The potential of TN-C Large as a unique biomarker
of joint disease/injury has been demonstrated using synovial ﬂuids
from humans with various joint diseases and from preclinical
animal models of joint injury. Being elastic, TN-C might play
an important role in degenerative/regenerative processes where
the normal biomechanical environment of musculoskeletal tissue
is compromised by disease/injury. As a binder of several ECM
proteins, release of TN-C could have a larger impact on the integral
structure/function of other ECM proteins, and has the potential to
be a marker of joint pathobiology and healing. Our preliminary
results indicate that TN-C levels may be applicable to determining
pharmacodynamic activity of chondro-protecting drugs in humans.
Work is ongoing to study the levels of TN-C during degeneration
in other joint tissues such as tendon. Understanding the functions
of TN-C would provide insights for pharmacologic intervention of
musculoskeletal diseases/injuries.
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DEGRADATION TO SYNTHESIS RATIOS OF TYPE II
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Purpose: Type II collagen biomarkers have shown promise in the
study of osteoarthritis. CPII (cleaved C-propeptide of type II colla-
gen) has been directly correlated with type II collagen synthesis.
CTX II (crosslinked C-telopeptide fragments of type II collagen),
C1,2C (neoepitope of types I and II collagen created after collage-
nase cleavage), and C2C (neoepitope of type II collagen created
after collagenase cleavage) have been used to assess collagen
degradation. The objective of the study was to compare type II
collagen degradation to synthesis ratios in serum and synovial
ﬂuid (SF) from normal horses and those with osteochondral (OC)
injury.
Methods: SF was taken from the carpal joints of 2 groups of
Thoroughbred racehorses: (1) normal, adult horses > 3 years of
age (2) OC injured horses 2-7 years of age undergoing arthro-
scopic surgery for removal of OC fragments resulting from racing
injury. From group 1 horses, serum was collected from 16 horses.
SF was obtained from 10 middle carpal joints (MCJ), and 10
radiocarpal joints (RCJ). From group 2, serum was collected from
20 horses. SF was collected from 10 MCJ and 10 RCJ. SF
was aseptically collected by needle arthrocentesis without lavage,
Abstract 115 – Table 1. Mean (± SD) concentrations of serum and SF type II collagen biomarkers and degradation to synthesis ratios for normal and osteochondral
(OC) injured carpal joints
Mean biomarker concentrations (± SD) Degradation:Synthesis
C2C (pmol/mL) C1,2C (pmol/mL) CTX II (pg/mL) CPII (ng/mL) C2C:CP II C1,2C:CP II CTX II:CP II
Serum
Normal 479±32.2 452±16*** 70.3±9.0** 1045±91 0.43±0.19 0.47±0.14* 0.07±0.03**
OC injured 415±9.8 580±21.6 39.6±3.4 1019±90 0.43±0.12 0.63±0.21 0.04±0.01
Synovial Fluid
Normal 274±15.6** 278±31.6*** 160±45*** 1013±60*** 0.26±0.06 0.22±0.05*** 0.08±0.05***
OC injured 409±32.6 1070±122 513±47.1 1637±110 0.26±0.09 0.65±0.37 0.37±0.28
Bolded values indicate a signiﬁcant difference between groups within serum or SF. *P≤0.05; **P≤0.01; ***P≤0.001.
centrifuged, and decanted. Commercially available ELISAs, were
used to measure type II collagen markers (C1,2C, C2C, CPII, and
CTX II). Differences between each group were evaluated using an
unpaired t-test. P<0.05 was considered signiﬁcant.
Results: Concentrations of C2C; C1,2C; and CTX II were all sig-
niﬁcantly higher in SF from OC injured joints compared to normal
joints (Table 1). Concentrations of CPII were also signiﬁcantly
higher in SF from injured joints compared to normal joints. Degra-
dation to synthesis ratios in SF were signiﬁcantly higher in OC
injured carpal joints compared to normal joints for C1,2C:CPII and
CTX II:CPII, but not for C2C:CPII. In serum, concentrations of
C1,2C were signiﬁcantly higher from OC injured horses compared
to normal horses. Serum concentrations of CTX II were signiﬁ-
cantly lower from OC injured horses compared to normal horses.
Serum ratios were signiﬁcantly higher in horses with OC injured
carpal joints compared to normal horses for C1,2C:CPII only. The
ratio was signiﬁcantly lower in serum from horses with OC injured
carpal joints compared to normal horses for CTX II:CPII only.
Conclusions: Joint injury affects concentrations of type II colla-
gen degradation and synthesis biomarkers and their ratios when
compared to normal horses. In SF, C1,2C:CPII and CTX II:CPII
ratios demonstrate that degradation predominates over synthe-
sis when the joint is injured because the ratios are higher than
normal joints. The serum C1,2C:CPII ratio suggests that there is
higher degradation after injury compared to normal horses with
no difference in the amount of synthesis. The CTX II:CPII ratio
suggests that the synthesis of type II collagen stays steady with
less degradation. However, increasing or decreasing degradation
to synthesis ratios must be interpreted in light of the known effect
of injury on biomarker concentrations in both SF and serum. Injury
may cause increase in SF concentrations, but may at the same
time cause an increase or decrease in serum concentrations.
Thus, SF biomarkers may be more indicative of degradation or
synthesis in a single joint than serum biomarkers.
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Purpose: Uric acid (UA) is constitutively present in normal cells,
increased in concentration when cells are injured and released
from dying cells. The products of cell stress and tissue damage
may represent “danger signals” that function as endogenous ad-
juvants recognized by the immune system. UA has been identiﬁed
as one of these principal endogenous “danger signals” released
from injured cells. We sought to determine whether elevated syn-
ovial ﬂuid (SF) UA might be a potentiating factor in osteoarthritis
(OA).
Methods: Patients: A total of 159 participants were enrolled in
the Strategies to Predict Osteoarthritis Progression (POP) study.
Informed consent was obtained from all subjects and the entire
study was approved by the Duke University IRB. Participants met
